Alternative splicing
Alternative splicing is a regulated process during gene expression that results in a single gene coding for multiple proteins. This process is a key factor in the complexity of proteins in eukaryotes and is one of the main reasons why eukaryotes can have a relatively small number of genes but a much larger number of proteins.
Overview[edit]
In the process of transcription, the gene is copied into messenger RNA (mRNA). This mRNA then undergoes a process called splicing where introns (non-coding regions) are removed and exons (coding regions) are joined together. In alternative splicing, different combinations of exons are joined together to form different mRNAs, which are then translated into different proteins.
Mechanism[edit]
Alternative splicing can occur in several ways. The most common types are exon skipping, intron retention, mutually exclusive exons, and alternative 5' or 3' splice sites. The choice of which exons to include in the mRNA is determined by a complex set of regulatory signals in the DNA and RNA, as well as proteins and small RNAs in the cell.
Regulation[edit]
The regulation of alternative splicing is a complex process that involves numerous trans-acting factors and cis-acting elements. Trans-acting factors are proteins and small RNAs that bind to the mRNA and influence the splicing process. Cis-acting elements are sequences in the DNA or RNA that influence splicing.
Role in disease[edit]
Abnormal alternative splicing has been implicated in numerous diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Understanding the mechanisms of alternative splicing and how it is regulated can therefore have important implications for the development of new treatments for these diseases.
See also[edit]
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
-
Alternative splicing
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian